TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY 26,562 28,647
-------------------------------------------------------------------------
-------------------------------------------------------------------------
NUVO RESEARCH INC.
CONSOLIDATED STATEMENTS OF LOSS, COMPREHENSIVE LOSS AND DEFICIT
Three-months ended
Unaudited March 31, March 31,
(thousands of Canadian dollars 2008 2007
except per share amounts) $ $
-------------------------------------------------------------------------
REVENUE
Product sales 1,975 702
Cost of goods sold 1,084 755
-------------------------------------------------------------------------
Gross margin (loss) on product sales 891 (53)
Other revenue
Licensing fees 250 250
Research and other contract revenue 11 26
-------------------------------------------------------------------------
1,152 223
-------------------------------------------------------------------------
EXPENSES
Research and development 2,104 1,746
Selling, general and administrative expenses 1,124 1,447
Stock-based compensation 150 163
Amortization of property, plant, and equipment
and intangibles 205 211
Foreign currency (gain) loss
'/>"/>
| SOURCE Nuvo Research Inc. Copyright©2008 PR Newswire. All rights reserved |